article thumbnail

PhRMA is going to have to write some big checks

World of DTC Marketing

The Pharmaceutical Research and Manufacturers of America raised nearly $527 million last year and spent roughly $506 million, new tax returns obtained by OpenSecrets reveal. That’s a record haul for the organization, which is funded by the world’s most powerful pharmaceutical companies. Leading lobbying industries in the U.S.

article thumbnail

And so pharma profiteers again

World of DTC Marketing

One of the biggest problems with a system that directs medical research towards profits rather than needs is that R&D funding is channelled to those products that can make pharma companies the most money. The best prospects are drugs targeted at patients who are high-value and who will use the drugs long term.

Pharma 191
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

US Democrats’ blockbuster budget bill could spell big changes for drug prices

pharmaphorum

Chief among these provisions is that the bill will allow, and indeed require, Medicare, the US’s government-run insurance program for older Americans, to negotiate drug prices with pharmaceutical companies in some cases, something it historically has not been allowed to do.

article thumbnail

Pharma’s ESG goals need to underscore push for health equity

Pharmaceutical Technology

Dall talked about GlobalData’s partnership with the trade organisation Pharmaceutical Research and Manufacturers of America (PhRMA), which has allowed for a focused effort to analyse and tackle health equity issues within the United States (US). . This trend continued in data presented surrounding the control of chronic diseases.